JPMorgan warns that MicroStrategy risks removal from the MSCI USA Index due to its exposure to Bitcoin. The removal could lead to reputation damage as it signals to active managers that MicroStrategy is a crypto treasury vehicle, not a software firm. Investment banking giant JPMorgan recently highlighted a structural vulnerability for Strategy Inc., formerly MicroStrategy [...]]]>JPMorgan warns that MicroStrategy risks removal from the MSCI USA Index due to its exposure to Bitcoin. The removal could lead to reputation damage as it signals to active managers that MicroStrategy is a crypto treasury vehicle, not a software firm. Investment banking giant JPMorgan recently highlighted a structural vulnerability for Strategy Inc., formerly MicroStrategy [...]]]>

JPMorgan Flags “Severe” Index Risk for MicroStrategy as BTC Exposure Raises Risk

  • JPMorgan warns that MicroStrategy risks removal from the MSCI USA Index due to its exposure to Bitcoin.
  • The removal could lead to reputation damage as it signals to active managers that MicroStrategy is a crypto treasury vehicle, not a software firm.

Investment banking giant JPMorgan recently highlighted a structural vulnerability for Strategy Inc., formerly MicroStrategy (MSTR). The bank warns that the company’s heavy reliance on Bitcoin (BTC) holdings could lead to its exclusion from major equity indexes.

JPMorgan Spotlight BTC Exposure Risk for MicroStrategy

JPMorgan disclosed in a recent note that Strategy may be removed from major equity indices, including the MSCI USA Index.

Thus, removal of Strategy from the MSCI USA Index would force passive investment funds to sell their MSTR holdings. This could trigger billions of dollars in immediate outflows from MSCI-linked funds and other providers, such as Russell or Nasdaq.

Top MSCI Index Could Bout MicroStrategyTop MSCI Index Could Bout MicroStrategy | Source: Matthew Sigel

The root of the JPMorgan note is ongoing consultation from MSCI about revising index rules. The MSCI USA Index, created by Morgan Stanley Capital International (MSCI), is a major stock market benchmark. The index tracks the performance of large and mid-cap U.S. companies, representing about 85% of the U.S. stock market.

MSCI is currently considering excluding companies where digital-asset holdings exceed 50% of total assets. Strategy clearly qualifies, as its BTC holdings dominate its $2.5 billion market cap.

This comes amid a broader crypto market downturn, with Bitcoin falling from its all-time high of around $126,000 in October to the $83,000 level as of this writing. This BTC price decline quickly magnified the MSTR stock decrease with little to no premium. 

In essence, Strategy has evolved from a traditional software firm into a Bitcoin proxy on the Nasdaq. This has allowed investors indirect exposure to BTC through stock indexes. 

However, new index eligibility rules are treating it more like a crypto investment fund than an operating business, which could increase selling pressure.

Strategy’s Bitcoin Accumulation Trend

The journey of Strategy into the Bitcoin market began in August 2020 under Executive Chairman Michael Saylor. The company started converting its balance sheet to BTC and later issued convertible debt and equity to fund further purchases.

In its latest BTC buy, Strategy announced it purchased an additional 487 BTC for approximately $49.9 million. The move reaffirms long-term confidence in Bitcoin’s growth potential, after the company paused purchases in October.

Before this purchase, Saylor faced criticism from stockholders. They accused Saylor of breaking previous assurances and moving forward with MSTR stock dilution for purchasing more Bitcoin.

As of November 17, 2025, Strategy holds 649,870 BTC, according to data from BitcoinTreasuries. At the current BTC price of around $83,000, these holdings are worth roughly $53.9 billion. While the company is still profitable, it is increasingly at risk due to the drop in BTC price.

According to the note from JPMorgan, premium compression eliminates the Strategy’s ability to issue high-priced equity to buy more BTC without diluting shareholders.

Furthermore, the company warned that about 15% further drop in BTC would wipe out gains on its entire position, pushing it into net losses.

]]>
Market Opportunity
Index Cooperative Logo
Index Cooperative Price(INDEX)
$0.535
$0.535$0.535
+5.48%
USD
Index Cooperative (INDEX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26